ArticleArthritis research & therapy2006

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.

Martin Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.